(September 11, 2023, 2:03 PM EDT) -- WASHINGTON, D.C. — The manufacturer of the abortion drug mifepristone and the U.S. Food and Drug Administration on Sept. 8 filed separate petitions for a writ of certiorari in the U.S. Supreme Court, arguing that the Fifth Circuit U.S. Court of Appeals erred in upholding a district court’s stay of the FDA’s 2016 amendments to mifepristone’s approval and the agency’s 2021 decision not to enforce its regulations during the COVID-19 pandemic....